SAGES 2008 Postgraduate Courses
Pearls & Pitfalls of Solid Organ MIS
Wednesday, April 9, 2008
7:00 AM - 12:00 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: George Ferzli, M.D.
Co-Chair: Eduardo Targarona, M.D.
The minimally invasive approach to solid organs is currently well established and accepted. However there are still a number of critical controversies. The course is intended to familiarize the participant with the current concepts, knowledge and versatility towards these specific situations.
Objectives:
At the conclusion of this session, the participant will be able to:
- Discuss the current knowledge in relation to selected controversial topics on MIS for solid organs.
- Discuss details and tricks (pearls) of this topic, as well as how to avoid the pitfalls during these operations.
| Schedule | ||
|---|---|---|
| 7:00 AM | Introduction |
George Ferzli, M.D. & Eduardo Targarona, M.D. |
| Spleen | ||
| 7:15 AM | How and When to Choose the Best Position for LS: Anterior, Lateral or Semilateral |
Eric Poulin, M.D. |
| 7:25 AM | HALS & Pre-op Embolization and Splenomegaly: Technique and Indications |
Andrea Pietrabissa, M.D. |
| 7:35 AM | Portal Vein Thrombosis After LS: Size of the Risk | Eduardo Targarona, M.D. |
| 7:45 AM | Partial Splenectomy | Selman Uranues, M.D. |
| 8:05 AM | Discussion | |
| Pancreas | ||
| 8:15 AM | MIS and Pacreatic Cancer: Which Link? | Horacio Asbun, M.D. |
| 8:25 AM | Cystic Tumors: How to Select the Approach? | Juan Pablo Pantoja, M.D. |
| 8:35 AM | Intra-op Ultrasound Localization, Central and Or/Distal Pancreatectomy or Enucleation: Tailoring the Technique | Laureano Fernandez Cruz, M.D. |
| 8:55 AM |
Pseudocyst: Laparoscopic, NOTES™ or Open | Adrian Park, M.D. |
| 9:10 AM | Discussion | |
| 9:20 AM | Break | |
| Liver |
||
| 9:30 AM | How, When and Why to Choose the Best Position for Hepatic Resection |
Namir Katkhouda, M.D. |
| 9:40 AM | MIS and Liver Cirrhosis: Good or Bad Friends? | Brice Gayet, M.D. |
| 10:00 AM | MIS Liver Surgerical Technique: Instrumentation, Energy Devices, HALS, Pre-op 3D, Imaging, Intr-op Ultrasound and Ablation Techniques | David Geller, M.D. |
| 10:10 AM | Discussion | |
| Adrenal | ||
| 10:20 AM | How to Choose the Best Position for Adrenalectomy: Anterior, Lateral or Semilateral | Emanuele Lezoche, M.D. |
| 10:30 AM | Limits and Strategy: Bilateral, Enlarged Adrenal and Partial Adrenalectomies | Quan Yang Duh, M.D. |
| 10:50 AM | Impact of Adrenalectomy of Metastasis on Long Term Outcome | Miguel Herrera, M.D. |
| 11:10 AM | Discussion | |
| Kidney |
||
| 11:20 AM | Live Kidney Donor: Left or Right?, HALS or Pure LAP | Kent Kerchner, M.D. |
| 11:30 PM | Radical MIS Nephrectomy: Adequate for Cancer? Total or Partial? |
Dennis Fowler, M.D. |
| 11:40 PM | Discussion |
|
Equipping the Surgeon–Training the Jedi: Series Focused on Optimizing Every Aspect of Your Surgical Career
Wednesday, April 9, 2008
7:00 AM - 12:00 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Blair Jobe, M.D., Co-Chair: Todd Heniford, M.D.
The purpose of this symposium is to provide participants with an overview of the most poignant issues currently encountered in the practice of surgery, and to provide practical strategies and tips for maximizing success in this milieu. In addition, this symposium will serve as a primer for residents and fellows, and provide tips on how to best prepare for success in surgery.
Objectives:
At the conclusion of the session, the participant will be able to:
- Been presented with strategies for maximizing success in specific techniques which are integral to the practice of minimal invasive and endoscopic surgery.
- An enhanced understanding of personal career direction and goals.
- Developed specific problem solving skills with regards to the practice of surgery.
- Developed skills for preventing perioperative complications in the surgical patient.
| Schedule | ||
|---|---|---|
| Protect – Prevent Perioperative Morbidity – Evidence-Based Pearls | ||
| 7:00 AM | Immunonutrition in Gastrointestinal Surgery – Does it Work? | Robert Martindale, M.D. |
| 7:15 AM | Prophulaxis in Bariatric Surgery – The Optimal Algorithm | Aurora Pyror, M.D. |
| 7:30 AM | Probiotics in Colorectal Surgery – Does it Prevent Colitis? | Dennis Fowler, M.D. |
| 7:45 AM | Cardiac Preparation and Perioperative Protection | Kevin Reavis, M.D. |
| Perform – Essential Techniques to Prevent Anastomotic Leak in Minimally Invasive and Endoscopic Surgery – A Video Series | ||
| 8:00 AM | Tension – Gastrojejunosotomy | Robert W. O’Rourke, M.D. |
| 8:10 AM | Ischemia – Esophagogastrostomy | Sebastian Gilbert, M.D. |
| 8:20 AM | Radiation – Estabishing GI Continuity after Rectal Cancer Resection | Mark Whiteford, M.D. |
| 8:30 AM | NOTES™ Gastrotomy Closure | Cedric Lorenzo, M.D. |
| 8:40 AM | Discussion for Protect and Perform | |
| Prevent – 5 Moves to Prevent Hernia Recurrence in Minmally Invasive Surgery | ||
| 8:50 AM | Paraesophageal | Brant Oelschlager, M.D. |
| 9:00 AM | Inguinal | Bruce Ramshaw, M.D. |
| 9:10 AM | Ventral | B. Todd Heniford, M.D. |
| 9:20 AM | Break | |
| Prepare – 5 Pieces of Equipment Essential to Your Success in Minimal Access Surgery | ||
| 9:35 AM | Colorectal | Tonia Young-Fadok, M.D. |
| 9:45 AM | Esophageal | Manisha Shende, M.D. |
| 9:55 AM | Hepatobiliary | Alan J. Koffron, M.D. |
| 10:05 AM | Endolumenal Surgery | Mike Owens, M.D. |
| 10:15 AM | Discussion for Prevent and Prepare | |
| Promote – A Career Development Primer | ||
| 10:25 AM | Success From the Beginning in Academics: How Do I Start? | Brent Matthews, M.D. |
| 10:40 AM | Negotiating the Promotion and Tenure Process | Gregory Stiegmann, M.D. |
| 10:55 AM | The Realities of Successful Research in Surgery | Jeffrey Peters, M.D. |
| Persevere – Top 10 Tips for Overcoming Commonly Encountered Obstacles | ||
| 11:10 AM | Addressing the Bottlenecks in Bariatric Treatment Pathways | Phillip Schauer, M.D. |
| 11:25 AM | New Skills Acquisition and Credentialing Post-Training | Fredrick Greene, M.D. |
| 11:40 AM | The Responsible Introduction of Novel Technologies into Practice | Bruce Schirmer, M.D. |
| 11:55 AM | Discussion for Promote and Persevere | |
Challenging Hernias
Wednesday, April 9, 2008
1:00 PM - 5:00 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Bruce Ramshaw, M.D. Co-Chair: Brent Matthews, M.D.
The SAGES Postgraduate Challenging Hernias Course is a half day course focusing on the management of difficult or atypical inguinal and abdominal wall hernias. Leading authorities will review preoperative planning and perioperative management, relevant anatomy, treatment options with an emphasis on complication prevention and management to improve outcomes for these challenging inguinal and ventral hernias. Management of patients with inguinodynia, infected mesh and enterotomies during laparoscopic ventral hernia repair will be discussed. An update on novel and evolving techniques in the repair of atypical abdominal wall hernia repairs will also be reviewed.
Objectives:
At the conclusion of the session, the participant will be able to:
- Discuss the management and prevention of complications during laparoscopic TAPP and TEP inguinal hernia repair and the repair of large scrotal hernias
- Review the management algorithm for inguinodynia
- Communicate treatment options for patients with infected mesh or enterotomy during laparoscopic ventral hernia repair
- Understand novel techniques to repair parastomal, flank, suprapubic, subxiphoid hernias and large ventral hernias with loss of abdominal domain
- Review techniques to prevent and manage recurrence after ventral hernia repair
| Schedule | ||
|---|---|---|
| Inguinal Hernia | ||
| 1:00 PM | TAPP – Complicated Cases: Managing and Preventing Complications and Recurrence | Neely Patton, M.D. |
| 1:15 PM | TEP – Complicated Cases: Managing and Preventing Complications and Recurrences | Guy Voeller, M.D. |
| 1:30 PM | The Large Scrotal Hernia | Gina Adrales, M.D. |
| 1:45 PM | Laparoscopic Approach for Mulitple Recurrent Hernias or Previous Preperitoneal Surgery or Mesh in the Extraperitoneal Space | Archana Ramaswamy, M.D. |
| 2:00 PM | Inguinodynia – What to Do? | Patricia Turner, M.D. |
| 2:15 PM | Management of Infected Mesh (Inguinal & Ventral) | Eduardo Parra-Davila, M.D. |
| 2:30 PM | Discussion | |
| 2:50 PM | Break | |
| Ventral Hernia | ||
| Atypical Locations | ||
| 3:05 PM | Suprapubic/Subxiphoid/Flank | B. Todd Heniford, M.D. |
| 3:20 PM | Parastomal | Kristi L. Harold, M.D. |
| 3:35 PM | Laparoscopic Approach for Giant Hernias/Loss of Domain | Bruce Ramshaw, M.D. |
| Complicated Cases | ||
| 3:50 PM | Enterotomy During Laparoscopic Ventral Hernia | Salvadore Morales-Conde, M.D. |
| 4:05 PM | Endoscopic Component Separation Technique | Michael Rosen, M.D. |
| 4:20 PM | Managing/Preventing Recurrence in Ventral Hernia Repair? | Brent D. Matthews, M.D. |
| 4:35 PM | Discussion | |
SAGES acknowledges generous educational grants in support of this course
from
Covidien and Tissue Science Laboratories.
MIS & Cancer
Wednesday, April 9, 2008
1:00 PM - 5:30 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Horacio Asbun, M.D., Co-Chair: Mark Talamini, M.D.
The role of minimal access surgery for resection of malignant neoplasms has been widely debated and remains an area of controversy for surgical oncologists. The key issue is to ensure safe, complete oncologic resections, and at the same time provide the additional benefits of the minimal access. The slow progress and acceptance of minimal access cancer surgery may also be related to limitations in the skill, training and experience in minimal access procedures specific to surgical oncology. The large majority of surgical oncology training programs have not widely embraced advanced laparoscopic techniques.
Because of major recent advances in systemic, regional cytotoxic and biologic therapy as well as nonresectional ablation techniques, the strict separation of curative and palliative surgical intervention has been somewhat obscured. Metastasectomy and cytoreductive surgery often include patients in whom the intent is less likely cancer cure and more centered on the intent to prolong life with cancer and improve quality of life. It is in this context minimal access surgery approaches may have a significant role by way of providing less traumatic and debilitating surgery when life span is limited and surgery likely non-curative.
Objectives:
At the completion of the course the attendees will be able to discuss:
- Current concepts in Minimal Access Surgery for Cancer
- Recent advances in cytotoxic agents as they relate to treatment of metastatic disease and its implication for surgery.
- Patient selection and timing for surgical therapy in the presence of metastatic disease.
- Percutaneous and minimal access surgery options.
- Intraoperative ultrasound techniques in liver surgery.
- Advanced minimal access surgical techniques and options in the treatment of metastatic disease.
| Schedule | ||
|---|---|---|
| 1:00 PM | Introduction | Horacio Asbun, M.D. & Mark Talamini, M.D. |
| 1:05 PM | Immunological Considerations in Minimal Access Surgery for Cancer | Richard L. Whelan, M.D. |
| 1:20 PM | Role of Minimal Access Surgery in Staging of Malignancies | Sherry Wren, M.D. |
| Minimal Access Surgery in the Treatment of Primary Malignancies: Current Status |
||
| 1:35 PM | MIS in Esophageal Cancer: Should it be the Standard of Care? | James Luketich, M.D. |
| 1:50 PM | MIS in Gastric Cancer: Current Status | Seigo Kitano, M.D. |
| 2:05 PM | Tips to Obtain an Oncologic Resection for Colon Cancer | James Fleshman, M.D. |
| 2:20 PM | Pancreas: What is the Role of MIS? | Horacio Asbun, M.D. |
| 2:35 PM | MIS for Splenic Malignancies | Eduardo Targarona, M.D. |
| 2:50 PM | Role of MIS in Pediatric Malignancies | Steven Rothenberg, M.D. |
| 3:05 PM | Panel Discussion | Mark Talamini, M.D. |
| 3:20 PM | Break | |
| Minimal Access Surgery and Metastesectomy | ||
| 3:45 PM | Neo-Adjuvant Treatment of the Initially Unresectable Liver Metastases from Colon Cancer: The Rules of Engagement are Changing | Pascal Fuchshuber, M.D. |
| 4:00 PM | Staged Hepatectomy Surgery for the Patient with Advanced Disease: Role of Pre-Operative Embolization | Andy Lowy, M.D. |
| 4:15 PM | Ablation of Liver Metastases: When? How? With What? | Allan Siperstein, M.D. |
| 4:30 PM | Laparoscopic Liver Resection for Metastatic Disease | David Geller, M.D. |
| 4:45 PM | Thoracoscopic Approaches to Lung Metastases | Steve Yang, M.D. |
| 5:00 PM | Laparoscopic Intraperitoneal Chemohyperthermia: Indications and Results | Vivian Strong, M.D. |
| 5:15 PM | Discussion | Horacio Asbun, M.D. |
SAGES acknowledges a generous educational grant in support of this course from Covidien
Pediatric Endosurgical Approaches: Past, Present & Future Pediatric Surgical Problems in Adults: Tag You’re It!
Wednesday, April 9, 2008
1:00 PM - 5:00 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Carroll “Mac” Harmon, M.D., Co-Chair: Timothy Kane, M.D.
Lecture session designed for senior Pediatric Surgery fellows, Pediatric surgeons, and General surgeons who will deal with patients with congenital anomalies when these patients become adults. Interactive lectures will be given by SAGES members who are leaders in the field of Pediatric Endosurgery. The first session will focus on the latest techniques and potential future applications for flexible endoscopic minimally invasive surgery for Pediatric surgical diseases. The second session will review several aspects of congenital abnormalities as they present in adult patients and how these may be handled.
Objectives:
At the conclusion of this session, participants will be able to:
- Review the latest in the treatment of pediatric surgical disease
- List several pediatric congenital anomalies, how they are treated and how they may be handled when the patient is an adult.
| Schedule | ||
|---|---|---|
| Through the Endoscope: Therapeutics, Present and Future Moderator: Carroll “Mac” Harmon, M.D. |
||
| Current Applications in Pediatric Endolumenal Surgery |
||
| 1:00 PM | Gastrointestinal Overview |
Carroll “Mac” Harmon, M.D. |
| 1:15 PM | Endobronchial Overview | John Waldhausen, M.D. |
| NEXT STEP Applications in Pediatric Endolumenal Surgery | ||
| 1:30 PM | Endolumenal Treatment of Intestinal Stenosis/Atresia | Timothy Kane, M.D. |
| 1:50 PM | Endolumenal Treatment of Gastroesophageal Reflux Disease | TBA |
| Future Applications in Pediatric Endolumenal Surgery | ||
| 2:05 PM | Endolumenal Treatment of Esophageal Atresia | Todd Ponsky, M.D. |
| 2:20 PM | Applications in Pediatric Anorectal Disease (Hirschsprung’s Disease, Imperforate Anus) | Keith Georgeson, M.D. |
| 2:40 PM | NOTES™ Possibilities | Jeffrey Ponsky, M.D. |
| 3:00 PM | Panel Discussion | |
| 3:25 PM | Break | |
| Pediatric Surgical Problems in Adults:
Tag You’re
It! Moderator: Whit Holcomb |
||
| 3:40 PM | Surprise! Your Adult Patient has Intestinal Malrotation | Whit Holcomb, M.D. |
| 3:55 PM | What to Expect in the Adult Surgical Patient Who was Born with a Major Pediatric Surgical Congenital Anomaly | Steven Rothenberg, M.D. |
| 4:10 PM | Colorectal Dysfunction in Adult Surgical Patients Secondary to Hirschsprung’s Disease or Imperforate Anus | Marc Levitt, M.D. |
| 4:25 PM | Kids with Chronic Pediatric Diseases Become Adult Surgical Patients | Thom Lobe, M.D. |
| 4:40 PM | Panel Discussion | |
Allied Health: The Evolution of Minimally Invasive Therapies: Impact on Today’s OR
Thursday, April 10, 2008
7:00 AM - 11:00 AM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Michael Holzman, M.D., Co-Chair: Cheryl Little, R.N. and Nadja Muchow, R.N.
The Allied Health session is designed to provide updates in some of the newer advances in clinical surgery. This years topics will give updates on the topics of endoscopy, bariatrics, hernias, robotics and OR technology. The format will include physician overviews along with nursing perspectives and insights. Allied health professionals attending the session should gain up to date knowledge in these rapidly advancing fields of surgery.
This year’s program will also include roundtable discussions for individuals to share experiences and protocols from their institutions with other programs. The interaction should allow for unique opportunities of all participants to share and gain knowledge from similar colleagues around the country.
Objectives:
At the conclusion of this session, participants will be able to:
- Discuss new developments in endolumenal and endoscopic therapies
- Review Laparoscopic Bariatric procedures
- List new materials used in hernia repairs
- List what is new in the OR environment
| Schedule | ||
|---|---|---|
| What’s New in Clinical Surgery | ||
| Endolumenal Therapies | ||
| 7:00 AM | Introduction | |
| 7:10 AM | N.O.T.E.S.™ – Endoscopic Therapies | Benjamin Poulose, M.D. |
| 7:30 AM | Nursing Topic for Endoscopy | Cheryl Little, M.N. |
| 7:45 AM | Surgical Therapy for Obesity | Edward Lin, M.D. |
| Hernia Repairs | ||
| 8:05 AM | Clinical Pathways – Impact on Care | Nadja Muchow, R.N. |
| 8:20 AM | Materials Update | Sharon Bachman, M.D. |
| 8:35 AM | Surgical Techniques | Michael Rosen, M.D. |
| 9:00 AM | Wounds Management and Outcomes | Michelle Vitamvas, R.N. |
| 9:15 AM | Break | |
| What’s New in the OR | ||
| 9:30 AM | Robotics in the OR | Dmitry Oleynikov, M.D. |
| 9:45 AM | Trouble Shooting the Video Systems | Barbie Lovett, R.N. |
| Round Table Discussions | ||
| 10:15 AM | Endoscopy | |
| 10:25 AM | Hernia | |
| 10:35 AM | Bariatric | |
| 10:45 AM | Operating Room Instrumentation and Safety | |
SAGES acknowledges our Gold Level Donors for their support of this course:
Stryker Endoscopy
Best of NOTES™ Session
Thursday, April 10, 2008
7:00 AM - 12:15 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: David Rattner, M.D., Co-Chair: Jeffrey Ponsky, M.D.
This course will present current information regardng the safety and efficacy of NOTES™ and evolving developments in the performance of NOTES™ procedures.
Objectives:
At the conclusion of this session, participants will be able to
- List the new findings regarding the safety and effectiveness of NOTES™.
- Review new technical advances in NOTES™.
- Discuss the evolving human trials of NOTES™.
| Schedule | ||
|---|---|---|
| 7:00 AM | Introduction | David Rattner, M.D. & Jeffrey Ponsky, M.D. |
| 7:05 AM | NOSCAR™ – What is it and Why Does it Matter? | David Rattner, M.D. |
| 7:15 AM | NOTES™ Access Routes and Access Closure | Richard Rothstein, M.D. |
| 7:45 AM | Infectious Issues and NOTES™: Laboratory Studies to Date, Sterile Conduits – Necessary or Not? | Michael McGee, M.D. |
| Economics of Device Development | ||
| 8:00 AM | The NOTES™ Toolkit – What We Need | Jacques Marescaux, M.D. |
| 8:15 AM | From Idea to Prototype | Paul Swain, M.D. |
| Platform Development | ||
| 8:30 AM | Retraction with Magnets | Daniel Scott, M.D. |
| 8:45 AM | Review of Current Multitasking Platforms | Christopher Thompson, M.D. |
| 9:00 AM | Robotics and NOTES™ | Santiago Horgan, M.D. |
| 9:15 AM | Discussion | |
| 9:35 AM | Break | |
| 9:50 AM | IRB Requirements for Human Procedures | Lee Swanstrom, M.D. |
| 10:05 AM | Human NOTES™ Procedures to Date International View | Ricardo Zoron, M.D. |
| 10:20 AM | Human NOTES™ in the USA | W. Scott Melvin, M.D. |
| 10:35 AM | Training and Credentialing for NOTES™ | Brian Dunkin, M.D. |
| 10:50 AM | NOTES™: Reimbursement Issues |
Steven Schwaitzberg, M.D. |
| 11:00 AM | First Debate | |
| NOTES™ Will Not Have a Significant Impact in MIS | C. Daniel Smith, M.D. | |
| NOTES™ is the Next Phase in MIS | Michael Marohn, M.D. | |
| The Future of NOTES™ is in the 3rd World | GV Rao, M.D. | |
| 11:30 AM | Second Debate: Visualization and Turf for NOTES™ | |
| Laparoscopic/Surgical Approach? | Jeffrey Hazey, M.D. | |
| Gastroenterologists Will Do NOTES™ | Anthony Kalloo, M.D. | |
| 12:00 PM | Discussion | |
SAGES acknowledges generous educational grants in support of this course
from
Covidien, Karl Storz Endoscopy-America, and Olympus Surgical America.
MIS & Rectal Disease
Thursday, April 10, 2008
7:00 AM - 12:00 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: John Marks, M.D., Co-Chair: Antonio Lacy, M.D.
Rectal cancer represents
a formidable problem to both the patient and surgeon alike. High local
recurrence rates, the challenge of operating in the deep pelvis and avoidance
of a permanent colostomy dominate treatment decisions regarding patients
with rectal cancer. The role of properly performed surgery and technique
focused training in combating poor outcome has been demonstrated. The ability
of neoadjuvant therapy to diminish local recurrence, improve survival and
alter surgical approaches extending sphincter preservation has also been
shown. Against this background the role of a minimally invasive techniques
must be evaluated.
This course will be of interest to all surgeons involved in the care of
rectal cancer. We will start by presenting an overview of the challenges
existing today in the treatment of rectal cancer. This will include world
authorities on the anatomy and staging of rectal cancer, the technique
of total mesorectal excision (TME) and novel approaches of neoadjuvant
therapy. From there, in a heavily video based session, we will move to
the various technical challenges and strategies for overcoming these problems
in the laparoscopic arena. Lastly we will discuss the role of endolumenal
approaches, using TEM to treat rectal cancer as well as the status of proposed
and ongoing trials to evaluate laparoscopic rectal cancer surgery, highlighting
the major controversies existing and being questioned in the arena of MIS
rectal cancer therapy.
Objectives:
At the conclusion of this session, participants will be able to:
- Describe the major issues surgeons face in the treatment of rectal cancer.
- Compare the imaging options available in the assessment of rectal cancer and how this distinguishes candidates for neoadjuvant therapy.
- Describe the fundamental aspects of TME surgery.
- Judge various strategies for laparoscopic pelvic surgery in the treatment of rectal cancer.
- Summarize the major difficulties faced in laparoscopic rectal surgery and the solutions presented to overcome these problems.
- Consider the results to date in
laparoscopic rectal cancer surgery and the role of a
prospective trial in differentiating outcomes compared to open surgery.
| Schedule | ||
|---|---|---|
| 7:00 AM | Introduction | John Marks, M.D. |
| 7:05 AM | Overview | Antonio Lacy, M.D. |
| 7:10 AM | Challenges in the Treatment of Rectal Cancer - 2008 |
Kirk Ludwig, M.D. |
| 7:25 AM | Pre-surgical Imaging | Gina Brown, M.D. |
| 7:40 AM | Role of Surgical Technique in Outcome | William Heald, M.D. |
| 7:55 AM | Role of Neoadjuvant Therapy | Mo Mohiuddin, M.D. |
| 8:10 AM | PANEL DISCUSSION | John Marks, M.D. |
| Problems/Challenges of Laparoscopic Rectal Surgery | ||
| 8:35 AM | Role of Hand Assisted Surgery vs. Pfannenesteil Approach in the Pelvis | Jeffrey Milsom, M.D. |
| 8:50 AM | Totally Laparoscopic Rectal Resection and Anastomosis | Morris Franklin, M.D. |
| 9:05 AM | Laparoscopic Approach to Low Anterior Resection – Exposure and Transection | Joel Leroy, M.D. |
| 9:20 AM | Laparoscopic Approach to the Distal Rectum with Coloanal Anastomosis: Lap TATA |
John Marks, M.D. |
| 9:35 AM | PANEL DISCUSSION | Antonio Lacy, M.D. |
| 10:05 AM | Coffee Break | |
| Current Status of Laparoscopic Rectal Surgery – Individual Experiences and Trials | ||
| 10:35 AM | The European Experience | Antonio Lacy, M.D. |
| 10:50 AM | The Need for a Laparoscopic Rectal Cancer Trial in the USA | James Fleshman, M.D. |
| 11:05 AM | Transanal Endoscopic Microsurgery and Neoadjuvant Therapy in the Treatment of Rectal Cancer | Emanuele Lezoche, M.D. |
| 11:20 AM | PANEL DISCUSSION | John Marks, M.D. |
| 11:50 AM | Conclusion/Summary | Antonio Lacy, M.D. |
SAGES acknowledges a generous educational grant in support of this course from Covidien
OR – Hospital of the Future Session
Thursday, April 10, 2008
1:00 PM - 3:30 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Adrian Park, M.D., Co-Chair: Richard Satava, M.D.
The operating room and the hospital of the future are going to be dramatically different than today, based on rapid advances and changes in technology, processes, behaviors, reimbursement and other factors. However, the biggest single factor will be the rapid changing technology. The fundamental change will be that “information”, in its broadest context, will dominate the new technology. Instruments, systems and even the operating room itself will become “smart”, with embedded intelligence into each component and with the capability of all these inanimate objects (instruments, rooms and systems) to communicate with each other and with humans - all autonomously. In short, there will be no distinction between “information” (which you cannot see or feel) and the objects they are integrated into (e.g. instruments, rooms). The result will be a reprioritizing on how we manage “operating room flow”. All of these technological changes will need to revolve around the patient, using the individual patient as the metric against which the added value is measured - if it doesn’t benefit the patient (e.g. quality, satisfaction, safety, etc.) then the technology should not be implemented.
Objectives:
After this session, participants will be able to:
- Understand the new technologies that are both here and on the horizon that will change the practice of surgery, especially in the operating room
- Understand the “big picture” of the fundamental changes that a surgeon will need to make in order to accommodate the new technologies
- Understand how technologies will benefit the patient, making the OR experience a safer, more satisfying experience
| Schedule | ||
|---|---|---|
| 1:00 PM | Introduction |
Adrian Park, M.D. |
| 1:05 PM | Overview | Richard Satava, M.D. |
| 1:10 PM | Information Systems Integration Into the “Peri-Operative” Setting |
Warren Sandberg, M.D. & Paul Nagy, M.D. |
| 1:25 PM | Artificial Intelligence Comes to the OR – Knowledge Management and Decision Support | David Masys, M.D. |
| 1:40 PM | Smart Surgical Image | Brent Seales, M.D. |
| 1:55 PM | The Future of Image Guided Therapies | Brad Wood, M.D. |
| 2:10 PM | Discussion | |
| 2:25 PM | Micro-Robots Loose in the Operating Room | Dmitry Oleynikov, M.D. |
| 2:40 PM | Human Factor/Interface Considerations in the “High Stakes Environment” |
U.S. Navy Tactical Aviator & Human Factors Officer |
| 2:55 PM | The Hospital of the Future | Orlando Portale, M.D. |
| 3:15 PM | Discussion | |
Motility Misery Session: A Growing Problem – Diagnosis and Management from Oropharynx to Anus
Thursday, April 10, 2008
1:00 PM - 5:00 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Brant Oelschlager, M.D., Co-Chair: Steven Wexner, M.D.
This session promises to be one of the most important at SAGES, and we promise to keep it interesting and practical. This course will present the major diagnostic and management options for patients with gastrointestinal motility disorders. Motility disorders are complex problems that surgeons are increasingly asked to manage, and occur frequently with our “functional” surgical interventions. The theme of this session will be practical approaches to these patients. Short talks will frame the major issues, followed by ample time for case presentations and questions to be discussed with our panel of experts. Please come to this session with your difficult cases for discussion.
Objectives:
At the conclusion of this session, participants will be able to:
- Assess the methods of evaluation of constipation, prolapse
and fecal incontinence
- Analyze the surgical alternatives for the treatment of constipation, prolapse and fecal incontinence
- Compare the results of surgical treatment of constipation, prolapse and fecal incontinence.
- Review the debate between partial and total fundoplication for GERD, especially in patients with esophageal motility disorders
- Review the differences between medical and surgical management of esophageal and gastric motor dysfunction
- List the keys to management of colonic motility disorders and pelvic floor dysfunction
| Schedule | ||
|---|---|---|
| GERD – Partial vs. Total Fundoplication – The
Ongoing Debate |
||
| 1:00 PM | Total Fundoplication | Lee Swanstrom, M.D. |
| 1:10 PM | Partial Fundoplication Lars Lundell, M.D. | |
| 1:20 PM | Cases and Discussion | |
| Primary Esophageal Disorders | ||
| 1:35 PM | Achalasia | Sumeet Mittal, M.D. |
| 1:45 PM | Surgical Therapy for Primary Esophageal Motility Disorders | Marco Patti, M.D. |
| 1:55 PM | Medical Treatment of Pre-Operative and Post-Operative Esophageal a Gastric Motility Disorder | Phil Katz, M.D. |
| 2:05 PM | Cases and Discussion | |
| Gastric Motility | ||
| 2:20 PM | Surgery for Gastroparesis | Fredrick Brody, M.D. |
| 2:30 PM | Esophageal and Gastric Motility in Bariatric Surgery | Peter Crookes, M.D. |
| 2:40 PM | Cases and Discussions | |
| 2:55 PM | Break | |
| Constipation & Prolapse | ||
| 3:10 PM | Evaluation | Dana Sands, M.D. |
| 3:20 PM | Surgical Treatment | David Beck, M.D. |
| 3:30 PM | Rectal Prolapse | John Marks, M.D. |
| 3:40 PM | Cases and Discussions | |
| Fecal Incontinence | ||
| 3:55 PM | Evaluation | Patricia Roberts, M.D. |
| 4:05 PM | Sphincter Repair for Fecal Incontinence | Ann Lowry, M.D. |
| 4:15 PM | New Surgical Alternatives for Fecal Incontinence (Including Sacral Nerve Stimulation, Stimulated Graciloplasty Artificial Bowel Sphincter) | Jonathan Efron, M.D. |
| 4:25 PM | Injectables for Fecal Inctontinence | Eric Weiss, M.D. |
| 4:35 PM | Cases and Discussions | |
Bariatric Surgery – Complex Cases and Controversial Issues
Thursday, April 10, 2008
1:00 PM - 5:00 PM
*Included in Registration SuperPass (Option A) or Registration Option B
Chair: Ninh T. Nguyen, M.D., Co-Chair: Ricardo Cohen, M.D.
This bariatric course provides expert advice in the management of common complex bariatric scenarios and presents some of the current controversial issues in bariatric surgery. The faculty will provide a short evidence-based overview of the literature to support their point and position. Complex scenarios in bariatric surgery will have real-life implications for clinical practice. Controversial issues in bariatric surgery will highlight emerging technology and an emerging indication for metabolic surgery in the non-obese population. This new area of “metabolic surgery” is sure to stimulate audience discussion and interaction.
Objectives:
At the conclusion of this session, participants will be able to:
- Understand the work-up and patient selection of complex bariatric patients.
- Learn the optimal surgical management for complex bariatric cases.
- Understand management strategy based on an evidence-based literature review.
- Understand the role of metabolic surgery.
| Schedule | ||
|---|---|---|
| 1:00 PM | Course Welcome and Introduction | Ninh Nguyen, M.D. & Ricardo Cohen, M.D. |
| Complex Bariatric Cases | ||
| 1:05 PM | Morbid Obesity with Giant Hiatal Hernia: Which Operation is Best? | Emma Patterson, M.D. |
| 1:20 PM | Morbid Obesity and Liver Cirrhosis: Operate or Not? | Giselle Hamad, M.D. |
| 1:35 PM | Failed Restrictive Operation: Revisional Surgery | Kelvin Higa, M.D. |
| 1:50 PM | Super-Super Obese: Band, Bypass, Sleeve or Staged Procedure? | Michel Gagner, M.D. |
| 2:05 PM | Laparoscopic Management of Bariatric Complications | Ninh Nguyen, M.D. |
| 2:20 PM | Q & A | |
| 2:40 PM | Break | |
| Controversial Issues in Bariatric Surgery | ||
| 3:00 PM | Morbid Obesity and Diabetes: Which Operation? | Philip Schauer, M.D. |
| 3:20 PM | Endoscopic Stoma or Pouch Reduction: Early Results | Dean Mikame, M.D. |
| 3:40 PM | The Role of Bariatric Surgery in a Renal Transplant Candidate | David Provost, M.D. |
| 4:00 PM | Bariatric Surgery in the Adolescent: Band, Bypass, or Sleeve? | Thomas Inge, M.D. |
| 4:20 PM | Metabolic Surgery for Type II Diabetes in the Non-Morbidly Obese | Ricardo Cohen, M.D. |
| 4:40 PM | Q & A | |
SAGES acknowledges a generous educational grant in support of this course
from
Covidien, Gore & Associates, and Karl Storz Endoscopy-America.